Low concentration meloxicam tablets

US9943486B2 · kind B2 · utility

Assignee

• BOEHRINGER INGELHEIM VETMEDICA GMBH · DE

Inventors

• Martin A. Folger · Ingelheim am Rhein, DE
• Stefan Lehner · Wiesbaden, DE
• Horst Schmitt · Nieder-Hilbersheim, DE

Key dates

• Filing date: Mar 13, 2013
• Grant date: Apr 17, 2018
• Expiry date: Mar 18, 2033

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K31/5415
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A solid tablet formed through direct compression of powder, the powder comprising meloxicam as an active ingredient and one or more excipients which are homogenously dispersed within the tablet that can be broken into two, three or four units with each unit containing equal amounts of the meloxicam.